• Reversine for Advanced Aurora Kinase Network Dissection

  2026-05-24

  Explore how Reversine, a potent Aurora kinase inhibitor, empowers researchers to dissect mitotic checkpoint complex regulation and apoptosis induction in cancer cells. This article uniquely connects molecular disruption, protocol precision, and the latest mechanistic insights for next-generation cancer research.

• Hematoxylin and Eosin Staining Kit: Protocol and Best Practi

  2026-05-23

  The Hematoxylin and Eosin Staining Kit (SKU: K1142) provides a ready-to-use solution for consistent histopathological and cytological tissue staining, enabling precise visualization of tissue morphology and cellular structures in research settings. This kit is designed for use with both paraffin-embedded and frozen tissue sections, but is not suitable for clinical diagnostics or medical decision-making.

• LDH Cytotoxicity Assay Kit: Benchmarking Biocompatibility in

  2026-05-22

  Discover how the LDH Cytotoxicity Assay Kit advances cell cytotoxicity measurement in the rigorous context of nanomaterial biocompatibility studies. This article offers a uniquely critical evaluation, integrating recent mechanistic insights and protocol optimization strategies.

• Ceftazidime in Advanced Resistance Profiling: Beyond β-Lacta

  2026-05-22

  Explore the scientific depth of Ceftazidime—a third-generation cephalosporin—delving into its role in resistance profiling and multidrug-resistant Gram-negative infection research. This article uniquely connects current transmission dynamics with practical assay design insights.

• Hematoxylin and Eosin Staining Kit: Practical Workflow Guide

  2026-05-21

  The Hematoxylin and Eosin Staining Kit (SKU: K1142) provides ready-to-use solutions for reliable visualization of tissue and cellular morphology in research applications. It is optimized for histopathological and cytological staining in paraffin-embedded or frozen tissue sections, but is not suitable for diagnostic or clinical use. Researchers benefit from streamlined preparation and consistent results when following best practice protocols.

• Transmission of Carbapenemase Genes in CREC During COVID-19

  2026-05-21

  This study systematically characterizes the prevalence, genetic localization, and transferability of carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae (CREC) from eight hospitals in Guangdong, China, during the COVID-19 pandemic. Its findings highlight a high frequency of plasmid-borne blaNDM-1 and significant multidrug resistance, with implications for infection control and antibiotic resistance research.

• Evaluating Dye Models for Small Tissue Biopsy Marking in His

  2026-05-20

  This study rigorously assesses various dyes for marking small tissue biopsies prior to histological processing, identifying hematoxylin as the most suitable for enhancing sample visibility without diagnostic interference. The findings inform improved protocols for tissue preservation and recognition in surgical pathology laboratories.

• DOT1L Inhibition by EPZ5676 Attenuates Renal Fibrosis via H3

  2026-05-20

  This study demonstrates that pharmacological inhibition of DOT1L with EPZ5676 reduces renal fibrosis by suppressing fibroblast activation and epithelial-mesenchymal transition in a murine model. The findings offer mechanistic insights into H3K79 methylation’s role in kidney disease and suggest epigenetic intervention as a promising strategy for fibrotic disorders.

• N6-Methyl-dATP: Redefining Epigenetic Tools for AML and Beyo

  2026-05-19

  This thought-leadership article explores the mechanistic and translational impact of N6-Methyl-dATP as an advanced probe for DNA replication fidelity, methylation modification research, and genomic stability epigenetics. By integrating recent findings on the LMO2/LDB1 axis in acute myeloid leukemia (AML) and mapping the competitive landscape, we provide strategic guidance for translational researchers seeking to bridge mechanistic discovery with clinical innovation. The discussion highlights APExBIO’s N6-Methyl-dATP and its unique translational promise, offering actionable protocol recommendations and a forward-looking perspective on the future of epigenetic nucleotide analogs in cancer and antiviral drug design.

• Bortezomib (PS-341) Workflows: Precision in Proteasome Resea

  2026-05-19

  Bortezomib (PS-341) empowers precision dissection of proteasome-regulated cellular processes and apoptosis in advanced oncology research. This guide details practical workflows, troubleshooting strategies, and experimental insights—bridging literature evidence and hands-on optimization for multiple myeloma, mantle cell lymphoma, and NSCLC models.

• Mitomycin C: Antitumor Antibiotic for DNA Replication Inhibi

  2026-05-18

  Mitomycin C is a potent antitumor antibiotic that exerts its effects by covalently binding DNA, inhibiting DNA synthesis and replication. It is widely used in apoptosis signaling research and cancer models due to its robust, p53-independent mechanism and synergy with TRAIL-induced apoptosis pathways.

• HATU in Peptide Synthesis: Applied Workflows and Troubleshoo

  2026-05-18

  HATU (1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate) from APExBIO streamlines peptide synthesis and amide bond formation with high yield and selectivity. This guide distills best practices, protocol enhancements, and real-world troubleshooting insights, empowering researchers to confidently tackle complex synthetic challenges.

• Applied Advantages of the Alcian Blue & Nuclear Fast Red Sta

  2026-05-17

  The Alcian Blue & Nuclear Fast Red Staining Kit, pH2.5, empowers high-contrast mucopolysaccharide detection and chondrogenic differentiation workflows, especially for small or challenging tissue samples. Its dual-staining protocol reduces preparation complexity and delivers reproducible results, making it a preferred choice for advanced histological research.

• JIB-04 Targets Colorectal Cancer Stem Cells via Wnt/β-Cateni

  2026-05-16

  The reference study demonstrates that JIB-04, a pan-selective histone demethylase inhibitor, selectively impairs colorectal cancer stem cell function by disrupting Wnt/β-catenin signaling. These findings highlight the promise of epigenetic pathway modulation for overcoming tumor recurrence and drug resistance in colorectal cancer.

• High-Throughput Gastruloid Arrays Reveal Developmental Varia

  2026-05-15

  This study pioneers a microraft array platform for large-scale, image-based screening and sorting of human gastruloids derived from pluripotent stem cells. The approach enables detailed phenotypic and gene expression analyses of individual gastruloids, uncovering heterogeneity and aberrant developmental phenotypes relevant to early human embryogenesis and congenital disease research.

16200 records 1/1080 page Next 12345 下5页 Last page